| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439265 | European Journal of Cancer | 2018 | 8 Pages |
Abstract
Osteoporosis treatment, including vitamin D and bisphosphonates, is associated with a 50% reduction of relapse and death in women treated with aromatase inhibitors for ER+ breast cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
B. Bouvard, J. Chatelais, P. Soulié, E. Hoppé, P. Saulnier, O. Capitain, M. Mege, N. Mesgouez-Nebout, E. Jadaud, S. Abadie-Lacourtoisie, M. Campone, E. Legrand,